Introduction
Myeloproliferative disorders (MPDs) are clonal disorders of the haematopoietic stem cells. These are classified as polycythaemia vera (PV), essential thrombocythaemia (ET), chronic myeloid leukaemia (CML) and myelofibrosis (MF) depending on the main haematopoietic lineage involved. Glomerulonephritis (GN) refers to a pattern of glomerular injury based on characteristic histopathology findings. GN associated with MPDs are rare in clinical practice. Although cases of polycythaemia with concomitant GN have occasionally been reported, there are few reports regarding PV. Amongst the few reported cases, focal segmental glomerulosclerosis (FSGS) is one of the most frequent forms that has been described. As far as we know PV associated with membranoproliferative glomerulonephritis (MPGN) has not been described before.
Case report
A 43-year old woman was admitted to hospital with a history of red eyes, painful red swollen hands and palpable erythematous rash over the limbs of three weeks duration. She also complained of headache and impaired vision. She was found to have high blood pressure one week prior to admission. On examination she was plethoric with conjunctival suffusion. Her hands were red and puffy. There was a palpable purpuric rash distributed predominantly in the extremities. Blood pressure was 110/90 mmHg. There was a 2 cm firm splenomegaly. Examination of the fundi revealed hyperaemic discs and tortuous vessels. Serum LDH was elevated. Serum erythropoietin was 4.6 IU/L (normal 3.7-29.5 IU/L). Vasulitic screening and ANA were negative. Serum complement levels were normal. Hepatitis B, C and HIV screening were negative. JAK2V617F and JAK2Exon12 mutations were absent. Bone marrow aspiration and trephine biopsy showed a markedly hypercellular marrow with erythroid predominance.
The diagnosis of (PV) was made as our patient fulfilled all three major criteria of polycythaemia vera study group (PVSG) diagnostic criteria. Due to constraints in assessing absolute red cell mass, indirect indices that reflect the red cell mass such as haemoglobin and haematocrit were considered. Percutaneous renal biopsy was performed to investigate proteinuria further and its findings confirmed MPGN.
Patient was subjected to several venesections once the diagnosis of PV was made and a target haematocrit of less than 45% was achieved during the hospital stay. She was started on aspirin and folic acid. Once the MPGN was diagnosed oral prednisolone was started 1mg/kg body weight/day. She was given nifedipine and captopril to keep the target blood pressure less than 120/70mmHg. Osteoporosis prophylaxis was started with alendronate. Currently she is on tapering doses of prednisolone and other medication. 24 hour urine protein excretion is checked every third month and the current value after six months of therapy is 0.357 g.
Discussion
MPGN may be primary or secondary. Majority of MPGNs are primary. The commonly identified secondary causes are autoimmune diseases, chronic viral, bacterial, protazoal infections, carcinoma of lung and breast, paraprotinaemias and chronic and recovered microangiopathies which includes polycythaemia [1] . Detection of MPGN is important as fifty percent of patients with MPGN develop end stage disease ten years after diagnosis, and ninety percent have renal insufficiency after twenty years. Early initiation of immunosuppressive treatment is worthwhile though there is only some evidence regarding steroids in MPGN [2] .
Polycythaemia may be primary which is known as PV or secondary. PV results from clonal expansion of a transformed haematopoietic stem cell. This is associated with a prominent overproduction of erythrocytes and to a lesser extent, expansion of the granulocytic and megakaryocytic elements. PV is usually associated with genetic mutations such as JAK2V617F and JAK2Exon12. There are case reports of PV associated with glomerulonephritis such as FSGS, membranous GN and IgA nephropathy [3] [4] [5] [6] [7] . But there are no reported cases of PV associated with MPGN to our knowledge.
Some case reports on PV and GNs show improvement of cell counts and proteinuria after repeated venesections alone. The improvement of cell counts in our patient with repeated venesections was not sustainable and there was no improvement of proteinuria. However once she was commenced on oral prednisolone, she showed a sustained improvement in cell counts with dramatic improvement in her proteinuria. She did not require any more venesections thereafter. Long-term follow-up of this patient will be required to show whether the remission of proteinuria indicates resolution of the renal changes and a good prognosis.
